Myeloid development is selectively disrupted in PU.1 null mice

Blood

Volumn 91, Issue 10, 1998, Pages 3702-3710

  Anderson, Karen L ^b   Smith, Kent A ^b   Conners, Kris ^b   McKercher, Scott R ^b   Maki, Richard A ^b   Torbett, Bruce E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL SPECIFICITY; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; GENE MUTATION; GROWTH REGULATION; LEUKOPOIESIS; LYMPHOPOIESIS; MACROPHAGE; MAST CELL; MONOCYTE; MOUSE; MYELOPOIESIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032525250     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3702.3702_3702_3710     Document Type: Article

References (40)

1. Shivdasani RA, Orkin SH: The transcriptional control of hematopoiesis. Blood 87:4025, 1996
2. Orkin SH: Transcription factors and hematopoietic development. J Biol Chem 270:4955, 1995
3. Kehrl JH: Hematopoietic lineage commitment: Role of transcription factors. Stem Cells 13:223, 1995
4. Janknecht R, Nordheim A: Gene regulation by Ets proteins. Biochim Biophys Acta 1155:346, 1993
5. Moreau-Gachelin F: Spi-1/PU.1: An oncogene of the Ets family. Biochim Biophys Acta 1198:149, 1994
6. Karim FD, Urness LD, Thummel CS, Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA, Gunther CV, Nye JA, Graves BJ: The ETS-domain: A new DNA binding motif that recognizes a purine-rich core DNA sequence. Genes Dev 4:1451, 1990
7. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA: The macrophage and B-cell specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113, 1990
8. Galson DL, Hensold JO, Bishop TR, Schalling M, D'Andrea AD, Jones C, Auron PE, Housman DE: Mouse β-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis. Mol Cell Biol 13:459, 1993
9. Voso MT, Burn TC, Wulf G, Lim B, Leone G, Tenen DG: Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Dev Biol 91:7932, 1994
10. Henkel G, Brown MA: PU.1 and GATA: Components of a mast cell-specific interleukin 4 intronic enhancer. Proc Natl Acad Sci USA 91:7737, 1994
11. Chen HM, Zhang P, Voso MT, Gonzalez DA, Glass CK, Zhang DE, Tenen DG: Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85:2918, 1995
12. Zhang D-E, Hohaus S, Voso MT, Chen H-M, Smith LT, Hetherington CJ, Tenen DG: Function of PU.1 (Spi-1), C/EBP, and AMLI in early myelopoiesis regulation of multiple myeloid CSF receptor promoters. Curr Top Microbiol Immunol 211:136, 1996
13. Zhang D-E, Hetherington CJ, Chen H-M, Tenen DG: The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol 14:373, 1994
14. Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang DE, Tenen DG: PU.1 (spi-1) and C/EBPα regulate expression of the granulocyte-macrophage colony stimulating factor receptor α. gene. Mol Cell Biol 15:5830, 1995
15. Smith LA, Gonzalez DA, Hohaus S, Voso MT, Sun Z, Tenen D: The myeloid specific granulocyte colony-stimulating factor (G-CSF) receptor promoter contains a functional site for the myeloid transcription factor PU.1 (Spi-1). Blood 84:372a, 1994 (suppl 1, abstr)
16. Miyajima A, Mui AL-F, Ogorochi T, Sakamaki K: Receptors for granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 5. Blood 82:1960, 1993
17. Avalos BR: Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88:761, 1996
18. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ, Maki RA: Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 15:5647, 1996
19. Scott EW, Simon MC, Anastasi J, Singh H: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573, 1994
20. Tondravi M, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL: Osteopetrosis in mice lacking hematopoietic transcription factor PU.1. Nature 386:81, 1997
21. Yam LT, Li CY, Crosby WH: Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55:283, 1971
22. Austyn JM, Gordon S: F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11:805, 1981
23. Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SE, Dubois CM, Kopp WC, Longo DL, Keller JR: Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 147:22, 1991
24. Heyworth CM, Spooncer E: In vitro clonal assays for murine multi-potential and lineage restricted myeloid progenitor cells, in Rickwood D, Hames BD (eds): Hematopoiesis: A Practical Approach. New York, NY, Oxford University Press, 1993
25. Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ: Studies of W mutant mice provide evidence for alternative mechanisms capable of activating hematopoietic stem cells. Exp Hematol 24:185, 1996
26. Lagasse E, Weissman IL: Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89:1021, 1997
27. Gilmore G, DePasquale D, Fischer B, Shadduck R: Enhancement of monocytopoiesis by granulocyte-stimulating factor: Evidence for secondary cytokine effects in vivo. Exp Hematol 23:1319, 1995
28. Kriegler AB, Verschoor SM, Bernardo D, Bertoncello I: The relationship between different high proliferative potential colony-forming cells in mouse bone marrow. Exp Hematol 22:434, 1994
29. McNiece IK, Williams NT, Johnson GR, Kriegler AB, Bradley TR, Hodgson GS: The generation of murine hematopoietic precursor cells from macrophage high proliferative potential-colony forming cells. Exp Hematol 15:972, 1987
30. Bradley TR, Hodgson GS: Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood 54:1446, 1979
31. Liu F, Wu HY, Wesselschmidt R, Kornaga T, Link DC: Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5:491, 1996
32. Lieschke GJ, Stanley E, Grail D, Hodgson G, Sinickas V, Gall JAM, Sinclair RA, Dunn AR: Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood 84:27, 1994
33. Seymour JF, Lieschke GJ, Stanley E, Grail D, Quillici C, Hodgson G, Dunn AR: Amyloidosis, hematopoietic and pulmonary abnormalities in mice deficient in both G-CSF and GM-CSF. Blood 86:593a, 1995 (suppl 1, abstr)
34. Till J, McCulloch E: A stochastic model of stem cell proliferation, based on the growth of colony-forming cells. Proc Natl Acad Sci USA 51:29, 1963
35. Nakahata T, Gross AJ, Ogawa M: A stochastic model of self-renewal and commitment to differentiation of the primitive hematopoietic stem cells in culture. J Cell Physiol 113:455, 1982
36. Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL: Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89:1033, 1997
37. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
38. Heyworth CM, Hampson J, Dexter TM, Walker F, Burgess AW, Kan O, Cook N, Vallance SJ, Whettod AD: Development of multipotent hematopoietic stem cells is associated with increased expression of receptors for granulocyte-macrophage colony-stimulating factor: Altered biological responses to GM-CSF during development. Growth Factors 5:87, 1991
39. Bellon T, Perrotti D, Calabretta B: Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter. Blood 90:1828, 1997
40. Scott EW, Fisher RC, Kehrli EW, Simon MC, Singh H: PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity 6:437, 1997